Permanent Hair Dyes and Chemical Straighteners May Be Linked to Breast Cancer, Study Says

Two common beauty products—permanent hair dyes and chemical straighteners—may be associated with an elevated risk for breast cancer, according to a new study published in the International Journal of Cancer.

Hair dyes have been linked to other cancers before, though the research is inconclusive. Bladder and blood cancers have been examined most closely, according to the American Cancer Society, with the most consistent results pointing to a small increase in bladder cancer risk for salon employees. Meanwhile, most studies to date looking specifically at dye and breast cancer have not found a connection.

The picture is similarly unclear for hair straighteners. While a major study using data from the mid-1990s did not find a link between straighteners and breast cancer, other, more recent studies have—and the researchers behind the new paper note that some straightening formulas popularized since the 1990s, namely keratin treatments, have been found to either contain the carcinogen formaldehyde, or release it during the application process.

The new study, which was funded by the National Institutes of Health (NIH) and the National Institute of Environmental Health Sciences, tracked 46,700 U.S. women enrolled in the Sister Study, which recruited breast-cancer-free women whose sisters had been diagnosed with the disease. At enrollment, the women ranged in age from 35 to 74. They answered questions about their health, lifestyle (including hair product use) and demographics at the beginning of the study, and provided researchers with updates over a follow-up period of, on average, eight years.

More than half of the women reported use of permanent hair dyes in the year before they joined the study, and about 10% said they had used chemical straighteners. These women, the researchers found, had a greater chance of being among the nearly 2,800 study participants who ended up developing breast cancer—especially if they identified as black.

Overall, using permanent dye was associated with a 9% higher risk of developing breast cancer, compared to non-use. But black women who used permanent dye had a 45% higher risk of breast cancer, compared to non-users, and those who used these products every eight weeks or more often had a 60% higher risk.

Black women were also far more likely to report using chemical straighteners—74% had, compared to 3% of white women—which were associated with an 18% higher risk of breast cancer in the study population as a whole.

Alexandra White, an National Institute of Environmental Health Sciences epidemiologist and one of the study authors, notes that this may be due to differences in the formulations of the dyes and straighteners used by women identifying as black compared to those identifying as white. Her co-author Dale Sandler adds that coarser, thicker hair may also absorb more dye. More research is required to confirm those hypotheses, but Sandler says it’s important for doctors to know about the differences, especially since black women are more likely to die from breast cancer than white women, and since most previous research on the health effects of hair dye have been on white women.

Dr. Nisha Unni, an assistant professor of hematology and oncology at the University of Texas Southwestern Medical Center, calls the finding “striking,” but notes that black women are known to be more likely than white women to develop the subtype of breast cancer that appeared most related to hair dye and straighteners. (The authors did not have the statistical power to fully tease out that relationship.) She also notes that, while the study was generally well-designed, it couldn’t isolate every factor that influences cancer risk. For example, people tend to get cancer as they age—and age-related graying may also boost hair dye use.

Unfortunately, White says there’s no quick fix or specific ingredient to avoid at this point. “Hair dye contains more than 5,000 different compounds…and formulas are constantly changing,” White says. “Some compounds have had more evidence to support their possible carcinogenicity than others.”

For breast cancer, she says some of the strongest evidence points to aromatic amines, colorless chemicals in hair dye that have been shown to bind to DNA in breast tissue, and potentially lead to DNA damage linked to cancer. Temporary and semi-permanent dyes, which were not strongly linked to an elevated breast cancer risk in the study, contain fewer aromatic amines, possibly making them safer than permanent dyes.

Findings aside, the study is a reminder that beauty and self-care products in the U.S. are not well-regulated. The vast majority of cosmetic products and ingredients do not need Food and Drug Administration approval or safety testing before they go to market, and the agency does not have the authority to recall tainted products. (One exception is color additives, which the FDA does regulate. In 2018, it ordered companies to reformulate products that contained lead acetate for this purpose, citing potential health risks.)

While it’s worth being conscious of the risks associated with cosmetics, White says it’s too soon to swear off hair dye. The study tracked a relatively small group of women who actually developed cancer, and the disease is almost never caused by one thing alone. “We know that a lot of different factors influence breast cancer risk,” White says.

Fiji to postpone sports contests as it battles measles outbreak

Fiji to postpone sports contests as it battles measles outbreak
Reuters: Health
Fiji has asked its sports federations to postpone all competitions until January, in a bid to rein in the spread of a measles outbreak that has killed dozens in the neighboring Pacific nation of Samoa.


Roche wins FDA approval for immunotherapy cocktail against lung cancer

Roche wins FDA approval for immunotherapy cocktail against lung cancer
Reuters: Health
Roche's Tecentriq immunotherapy mixed with chemotherapy won U.S. approval as an initial treatment for a form of lung cancer as the Swiss drugmaker seeks to establish its alternative to drugs from Merck and Bristol-Myers Squibb.


Insurance Coverage Parity for Mental Health Concerns Is Getting Worse

As a testament to the ineffectiveness of laws when not rigorously enforced (hello, speed limit, I’m looking at you!), the lack of enforcement on mental health parity has been devastating. Mental health parity means that insurance companies are required, by law, to offer the same coverage and benefits for mental disorders as they do for physical conditions.

When an American seeks treatment for a mental health or substance abuse problem, chances are they are going to face some pretty steep hurdles. And those hurdles are only getting worse before they get better, according to a new study examining insurance claim data from 2016-2017.

The new study was funded by the Bowman Family Foundation and published by Milliman. It looked at the insurance claims data — the paperwork providers file with an insurance company in order to get paid.

The research shares some disappointing data, including this bombshell: “In 2017, out-of-network use for behavioral health was 520% more likely than for medical/surgical, up from 280% in 2013.”

What that means is that nearly twice as many Americans are turning to mental health professionals outside of their insurance’s network of covered providers in 2017 than in 2013. Why is that? Likely because insurance companies notoriously compile and maintain out-of-date, ghost provider databases of mental health professionals that supposedly are accepting new clients — but aren’t.

These ghost directories (or ghost networks) are so-called because many — and in some cases, most — of the professionals listed for many behavioral healthcare specialties (such as psychiatry) don’t actually take new patients. That means it is virtually impossible to actually get an appointment with a professional covered by your insurance company.

Customers of the insurance company are forced to call around, going down the entire list of providers listed in the company’s database, trying to find a professional who take them. In the case of a psychiatrist, for instance, if a person does find one willing to take on new patients, the wait time for the first appointment is measured in months, instead of days.

This is not parity. Compared to getting an appointment with an internist or primary care physician, there exists a large and growing disparity between coverage between mental health and physical concerns.

Exasperated by waiting, or finding no professionals actually open to new clients, customers are going “out of network” to find a professional who will take them in a reasonable amount of time. Even if it means paying more for their care and treatment.

Most people don’t experience anything quite like this when needing to consult a medical professional for a traditional physical disease.

Substance Abuse Treatment Is Even Worse

Not surprising, substance abuse treatment was even worse. Patients seeking treatment for opioid addiction or some other substance abuse problem were 1000% more likely to use an out-of-network provider when compared to medical/surgical care in 2017.

This statistic was also double the finding from 2013, when it was still an astonishing 470%.

Worse yet, the reimbursement rate disparities for these kinds of issues increased every year too, when compared against traditional medical/surgical reimbursement rates.

Children’s Mental Health Care Is Worse Than Adults

According to the new report, in 2017, if your child needed to see a behavioral healthcare provider — such as a child psychologist — Americans were 10.1 times more likely to see a professional out-of-network than if they were seeing a primary care provider. This finding was twice the disparity the study found for adults.

This, again, is due to the lack of child mental health specialists being unavailable in an insurance company’s network.

Insurance Companies Pay More to Treat & Cover Physical Diseases Over Mental Disorders

The study also found a consistent disparity between what insurance companies pay professionals based upon the type of office visit they make. The study discovered that primary care reimbursements were nearly 24 percent higher when compared to reimbursing for behavioral health care visits.

And in some cases — 11 states in all — that difference grows to a whopping 50 percent greater reimbursement rate. It’s no wonder it’s getting harder and harder to convince medical students to go into psychiatry or other behavioral healthcare professions. Despite it being illegal to do so, insurance companies still treat both professionals and their patients seeking mental health treatment as second-class citizens. Every action they take demonstrates this attitude toward mental health care.

What Can Be Done About It?

While the federal government passed laws to prevent this sort of disparity from occurring — in both 1996 and again in 2008 — it’s clear the laws aren’t working in the way they were intended. Insurance companies continue to discriminate against people with mental disorders and needing mental health treatment. Instead of creating equalness between physical and mental conditions, it’s clear from this study’s data that the differences are actually increasing instead of decreasing.

Congress can readily provide the resources needed to enforce these laws and call out insurance companies who are continuing to provide ghost networks of behavioral healthcare providers, as well as those who continue to put limits on how mental health care is delivered compared to the delivery of primary care. More should be done to rectify the difference in reimbursement rates, to acknowledge the importance and difficulty in treating mental health conditions.

Read the full report: Addiction and mental health vs. physical health: Widening disparities in network use and provider reimbursement (PDF)

Israeli scientists find way to treat deadly pancreatic cancer in 14 days | The Jerusalem post

Israeli scientists find way to treat deadly pancreatic cancer in 14 days | The Jerusalem post submitted by /u/r4816
[link] [comments]


source https://www.reddit.com/r/Health/comments/e5qkm0/israeli_scientists_find_way_to_treat_deadly/

PrEP to Be Available for Free Even If You're Uninsured: The federal government today announced the procedure for applying for free HIV prevention drugs.

PrEP to Be Available for Free Even If You're Uninsured: The federal government today announced the procedure for applying for free HIV prevention drugs. submitted by /u/j_miles
[link] [comments]


source https://www.reddit.com/r/Health/comments/e5rfe0/prep_to_be_available_for_free_even_if_youre/

'So If You're Poor, You're Dead'? Watch These Brits Gasp When They Find Out Cost of Healthcare in the United States

'So If You're Poor, You're Dead'? Watch These Brits Gasp When They Find Out Cost of Healthcare in the United States submitted by /u/r4816
[link] [comments]


source https://www.reddit.com/r/Health/comments/e5qkx2/so_if_youre_poor_youre_dead_watch_these_brits/